Uterine Leiomyosarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution's Experience

Lusby, Kristelle; Savannah, Kari; Demicco, Elizabeth; Zhang, Yiqun; Ghadimi, Markus; Young, Eric; Colombo, Chiara; Lam, Ryan; Dogan, Tugce; Hornick, Jason; Lazar, Alexander; Hunt, Kelly; Anderson, Matthew; Creighton, Chad; Lev, Dina; Pollock, Raphael
July 2013
Annals of Surgical Oncology: An Oncology Journal for Surgeons;Jul2013, Vol. 20 Issue 7, p2364
Academic Journal
No abstract available.


Related Articles

  • Is There Negative Impact from Morcellation in Unsuspected Leiomyosarcoma? Coleman, Robert L. // OB/GYN Clinical Alert;Jul2011, Vol. 28 Issue 3, p21 

    Uterine morcellation procedures are common in the management of uterine leiomyomata, but may adversely impact outcomes and patterns of recurrence when performed in the setting of leiomyosarcoma.

  • The role of lymphadenectomy in uterine leiomyosarcoma: review of the literature and recommendations for the standard surgical procedure. Dafopoulos, Alexandros; Tsikouras, Panagiotis; Dimitraki, Marina; Galazios, Georgios; Liberis, Vasileios; Maroulis, Georgios; Teichmann, Alexander // Archives of Gynecology & Obstetrics;Dec2010, Vol. 282 Issue 3, p293 

    Uterine sarcomas are rare and aggressive gynaecologic malignancies with poor prognosis, arising from myometrial or endometrial tissue. These rare cancers can be aggressive, and account for a greatly disproportionate amount of deaths from uterine cancers. The histological uterine sarcomas...

  • Involvement of proteasome β1i subunit, LMP2, on development of uterin leiomyosarcma. Hayashi, Takuma; Horiuchi, Akiko; Sano, Kenji; Hiraoka, Nobuyoshi; Kasai, Mari; Ichimura, Tomoyuki; Nagase, Satoru; Ishiko, Osamu; Shiozawa, Tanri; Kanai, Yae; Yaegashi, Nobuo; Aburatani, Hiroyuki; Tonegawa, Susumu; Konishi, Ikuo // North American Journal of Medical Sciences;Sep2011, Vol. 3 Issue 9, p394 

    Background: Although the majority of smooth muscle neoplasms found in the uterus are benign, uterine leiomyosarcoma is extremely malignant, with high rates of recurrence and metastasis. The development of gynecologic tumors is often correlated with secretion of female hormone; however, the...

  • Uterine smooth muscle tumors: the benign, the bizarre, and the deadly. Giuntoli, Robert L.; Bristow, Robert E. // Contemporary OB/GYN;Aug2006, Vol. 51 Issue 8, p50 

    The article provides information on uterine smooth muscle tumors. Uterine leiomyomata or fibroids are benign smooth muscle tumors that are common in women. Uterine leiomyosarcoma, on the other hand, are rare and clinically aggressive malignancies. The author describes the criteria and management...

  • A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors. Lee, Cheng-Han; Turbin, Dmitry A; Sung, Y-C Vanessa; Espinosa, Inigo; Montgomery, Kelli; van de Rijn, Matt; Gilks, C Blake // Modern Pathology;Dec2009, Vol. 22 Issue 12, p1519 

    No abstract available.

  • Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas. Mittal, Khush R; Chen, Fan; Wei, Jian J; Rijhvani, Kiran; Kurvathi, Rohini; Streck, Deanna; Dermody, James; Toruner, Gokce A // Modern Pathology;Oct2009, Vol. 22 Issue 10, p1303 

    No abstract available.

  • Systemic Biomarkers in the Evaluation and Management of COPD Patients: Are We Getting Closer to Clinical Application? Kostikas, Konstantinos; Bakakos, Petros; Papiris, Spyros; Stolz, Daiana; Celli, Bartolome R. // Current Drug Targets;Jan2013, Vol. 14 Issue 1, p177 

    Chronic obstructive pulmonary disease (COPD) is a complex, multicomponent disease at the clinical, cellular, and molecular levels. Over the past few years there has been a growing interest in the field of biomarkers in COPD and a large number of studies have evaluated potential candidate...

  • Obstructive Small Bowel Metastasis from Uterine Leiomyosarcoma: A Case Report. Tunio, Mutahir A.; AlAsiri, Mushabbab; Saleh, Rasha M.; Akbar, Shomaila Amir; Ali, Nagoud M.; Senosy Hassan, Mohamed Abdalazez // Case Reports in Obstetrics & Gynecology;2014, p1 

    Background. Uterine leiomyosarcoma is a rare and aggressive gynecologic malignancy with an overall poor prognosis. Lungs, bones, and brain are common sites of metastases of uterine leiomyosarcoma. Metastases of uterine leiomyosarcoma to the small bowel are extremely rare, and only four case...

  • Primary intracranial leiomyosarcoma of the torcular Herophili associated with Fanconi anemia and allogenic stem cell transplantation. Aumüller, Michèle; Sykora, Karl-Walter; Hartmann, Christian; Hermann, Elvis; Krauss, Joachim // Child's Nervous System;Sep2014, Vol. 30 Issue 9, p1613 

    Purpose: Fanconi anemia is associated with a high risk for developing malignant tumors. The occurrence of primary intracranial leiomyosarcoma, however, which in general has a poor prognosis, has not been described thus far. The purpose of this study is to report on management and outcome of...

  • Select Biomarkers for Tumors of the Gastrointestinal Tract. Bartley, Angela N.; Hamilton, Stanley R. // Archives of Pathology & Laboratory Medicine;Apr2015, Vol. 139 Issue 4, p457 

    Context .- Advances in molecular biomarkers of the gastrointestinal tract have contributed to a decline in the incidence of and mortality from diseases of the gastrointestinal tract. The discovery and clinical validation of new biomarkers are important to personalized cancer therapy, and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics